SyStemix deal

Sandoz Pharma Ltd. has elected to end a June 1992 human stem cell growth factor research collaboration with the Palo Alto company, under terms that permitted termination after 18 months. STMX and Sandoz were working to identify and isolate a gene that encodes a growth factor responsible for human stem cell self-renewal. ...